Impact of highly active antiretroviral therapy on the occurrence of bacteraemia in HIV-infected patients and their epidemiologic characteristics

HIV Medicine

Volumn 4, Issue 2, 2003, Pages 127-132

  Meynard, Jean Luc ^a   Guiguet, M ^a   Fonquernie, L ^a   Lefebvre, B ^a   Lalande, V ^a   Honore, I ^a   Meyohas, M C ^a   Girard, P M ^a  

^a HÔPITAL SAINT ANTOINE   (France)

Author keywords

AIDS; Bacteraemia; HAART

Indexed keywords

AMPICILLIN; ANTIRETROVIRUS AGENT; CD4 ANTIGEN; CIPROFLOXACIN; COTRIMOXAZOLE; INDINAVIR; LAMIVUDINE; PENICILLIN G; PROTEINASE INHIBITOR; RITONAVIR; SAQUINAVIR; STAVUDINE; TICARCILLIN; ZIDOVUDINE;

ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTEREMIA; BLOOD CULTURE; CASE CONTROL STUDY; CATHETER INFECTION; CONTROLLED STUDY; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HOSPITAL INFECTION; HOSPITALIZATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; REVIEW; RISK FACTOR; STATISTICAL SIGNIFICANCE;

ADULT; ANTI-BACTERIAL AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BACTEREMIA; CASE-CONTROL STUDIES; CD4 LYMPHOCYTE COUNT; CHI-SQUARE DISTRIBUTION; CROSS INFECTION; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION;

EID: 0038324200     PISSN: 14642662     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1468-1293.2003.00146.x     Document Type: Review

References (26)

1. Witt DJ, Craven DE, McCabe WR et al. Bacterial infection in adult patients with the acquired immune deficiency syndrome (AIDS) and AIDS related complex. Am J Med 1987; 82: 900-906.
2. Simberkoff MS, Leaf HL. Bacterial infections in patients with HIV infection. In: Wormser EP, ed. AIDS and Other Manifestation of HIV Infection. 2nd edn. New York, Raven Press, 1992: 269-275.
3. Zurlo JJ, Lane HC. Other bacterial infection. In: De Vita VT, Hellman S, Rosemberg SA, eds. AIDS. Etiology, Diagnosis, Treatment and Prevention, 4th edn. Philadelphia, New York, Lippincott-Raven, 1997: 259-265.
4. Baril L, Astagneau P, Nguyen J et al. Pyogenic bacterial pneumonia in human immunodeficiency virus-infected inpatients: a clinical, radiological, microbiological, and epidemiological study. Clin Infect Dis 1998; 26: 964-971.
5. Hirschtick RE, Glassroth J, Jordan MC. Bacterial pneumonia in persons infected with the human immunodeficiency virus. New Engl J Med 1995; 333: 845-851.
6. Tumbarello M, Taconelli E, De Gaetano K et al. Bacterial pneumonia in HIV infected patients. Analysis of risk and prognostic indicators. J Acquir Immune Defic Syndr Human Retrovirol 1998; 18: 39-45.
7. Tumbarello M, Taconelli E, Caponera S, Cauda R, Ortona L. The impact of bacteremia on HIV infection. Nine years experience in a large Italian University hospital. J Infect 1995; 31: 123-131.
8. Fichtenbbaum CJ, Claiboune Dunagan W, Powderly WG. Bacteremia in hospitalized patients infected with HIV; a case control study of risk factors and outcome. J Acquir Immune Defic Syndr Hum Retrovirol 1995; 8: 51-57.
9. Skoutelis AT, Murphy RL, McDoneel KB, Von Roenn JH, Sterkel CD, Phair JP. Indwelling central vvenous catheter infections in patients with immune deficiency syndrome. J Acquir Immune Defic Syndr 1990; 3: 335-342.
10. Longuet P, Douard MC, Arlet G, Molina JM, Benoit C, Leport C. Venous acces port-related bacteremia in patients with acquired immunodeficiency syndrome or cancer. The reservoir as a diagnostic and therapeutic tool. Clin Infect Dis 2001; 32: 1776-1783.
11. Tumbarello M, Taconelli E, De Gaetano Donati K et al. Nosocomial bloostream infections in HIV-infected patient: attribuable mortality and excess hospital stay. J Acquir Immune Defic Syndr 1998; 19: 490-496.
12. Palella FJ Jr, Delaney KM, Moorman AC et al. Declining morbidity and mortality among patients with advanced humen immunodeficiency virus infection. HIV outpatient study investigators. New Engl J Med 1998; 338: 853-860.
13. Paul S, Gilbert HM, Ziecheck W, Jacobs J, Sepkowitz KA. The impact of potent antiretroviral therapy on the characteristics of hospitalized patients with HIV infections. AIDS 1999; 13: 415-418.
14. Detels R, Tarwater P, Phair JP, Margolick J, Riddler SA, Munoz A. Multicenter AIDS, Cohort Study. Effectiveness of potent antiretroviral therapies on the incidence of opportunistic infections before and after AIDS diagnosis. AIDS 2001; 15: 347-355.
15. Ledergerber B, Mocroft A, Reiss P et al. Discontinuation of secondary prophylaxis against Pneumocystis carinii pneumonia in patients with HIV infection who have a response to antiretroviral therapy. New Engl J Med 2001; 344: 168-174.
16. Lopez Bernaldo de Quiros JC, Miro JM, Peña JM et al. A randomized trial of the discontinuation of primary and secondary prophylaxis against Pneumocystis carinii pneumonia after highly active antiretroviral therapy in patients with HIV infection. New Engl J Med 2001; 344: 159-167.
17. Jouan M, Saves M, Tubiana R, Carcelain G et al. Discontinuation of maintenance therapy for cytomegalovirus retinitis in HIV-infected patients receiving highly active antiretroviral therapy. AIDS 2001; 5: 23-31.
18. Tumbarello M, Taconelli E, De Gaetano Donati K et al. HIV-associated bacteremia: how it has changed in the highly active antiretroviral therapy (HAART) era. J Acquir Immune Defic Syndr 2000; 23: 145-151.
19. De Gaetano Donati K, Bertagnolio S, Tumbarello M et al. Effect of highly active antiretroviral therapy on the incidence of bacterial pneumonia in HIV-infected patients. Int J Antimicrob Agents 2000; 16: 357-360.
20. U.S. Department of Health and Human Services. National Nosocomial Infection Surveillance Manual. Atlanta, Centers for Disease Control, January 1988.
21. Brun-Buisson C, Abrouk E, Legrand P, Huet Y, Larabi S, Rapin M. Diagnosis of central venous catheter-related sepsis: critical level of quantitative tip cultures. Arch Intern Med 1987; 147: 873-877.
22. Acar J, Bergogne-Berezin E, Chardon H et al. Communiqué 1994. Path Biol 1994; 42: 1-8.
23. Mouton Y, Alfandari S, Valette M et al. Impact of protease inhibitors on aids events and hospitalization in 10 French AIDS reference centres. AIDS 1997; 11: F101-F105.
24. Senthilkumar A, Kumar S, Sheagren JN. Increased incidence of Staphylococcus aureus bacteremia in hospitalized patients with acquired immunodeficiency syndrome. Clin Infect Dis 2001; 33: 1412-1416.
25. Dworkin MS, Ward JW, Hanson DL et al. Pneumococcal disease among human immunodeficiency virus-infected persons: incidence, risk factors, and impact of vaccination. Clin Inf Dis 2001; 32: 794-800.
26. Meynard JL, Barbut F, Guiguet F et al. Pseudomonas aeruginosa infection in human immunodeficiency virus infected patients. J Infection 1999; 38: 176-181.